Computational Drug Repurposing for Antituberculosis Therapy: Discovery of Multi-Strain Inhibitors

Tuberculosis remains the most afflicting infectious disease known by humankind, with one quarter of the population estimated to have it in the latent state. Discovering antituberculosis drugs is a challenging, complex, expensive, and time-consuming task. To overcome the substantial costs and acceler...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleandrova, Valeria V., Scotti, Marcus T., Speck-Planche, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388932/
https://www.ncbi.nlm.nih.gov/pubmed/34439055
http://dx.doi.org/10.3390/antibiotics10081005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388932/
https://www.ncbi.nlm.nih.gov/pubmed/34439055
http://dx.doi.org/10.3390/antibiotics10081005

Ejemplares similares